Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. (Q55561847)
Jump to navigation
Jump to search
scientific article published on 6 July 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. |
scientific article published on 6 July 2018 |
Statements
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. (English)
1 reference
Alexandra R Harris
1 reference
Matthew J Perez
1 reference
6 July 2018
1 reference
1 reference
18
1 reference
1
1 reference
718
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference